TY - JOUR
T1 - Five-class differential diagnostics of neurodegenerative diseases using random undersampling boosting
AU - Tong, Tong
AU - Ledig, Christian
AU - Guerrero, Ricardo
AU - Schuh, Andreas
AU - Koikkalainen, Juha
AU - Tolonen, Antti
AU - Rhodius, Hanneke
AU - Barkhof, Frederik
AU - Tijms, Betty
AU - Lemstra, Afina W.
AU - Soininen, Hilkka
AU - Remes, Anne M.
AU - Waldemar, Gunhild
AU - Hasselbalch, Steen
AU - Mecocci, Patrizia
AU - Baroni, Marta
AU - Lötjönen, Jyrki
AU - Flier, Wiesje van der
AU - Rueckert, Daniel
PY - 2017/1/1
Y1 - 2017/1/1
N2 - Differentiating between different types of
neurodegenerative diseases is not only crucial in
clinical practice when treatment decisions have to be
made, but also has a significant potential for the
enrichment of clinical trials. The purpose of this study
is to develop a classification framework for
distinguishing the four most common neurodegenerative
diseases, including Alzheimer's disease, frontotemporal
lobe degeneration, Dementia with Lewy bodies and vascular
dementia, as well as patients with subjective memory
complaints. Different biomarkers including features from
images (volume features, region-wise grading features)
and non-imaging features (CSF measures) were extracted
for each subject. In clinical practice, the prevalence of
different dementia types is imbalanced, posing challenges
for learning an effective classification model.
Therefore, we propose the use of the RUSBoost algorithm
in order to train classifiers and to handle the class
imbalance training problem. Furthermore, a multi-class
feature selection method based on sparsity is integrated
into the proposed framework to improve the classification
performance. It also provides a way for investigating the
importance of different features and regions. Using a
dataset of 500 subjects, the proposed framework achieved
a high accuracy of 75.2% with a balanced accuracy of
69.3% for the five-class classification using ten-fold
cross validation, which is significantly better than the
results using support vector machine or random forest,
demonstrating the feasibility of the proposed framework
to support clinical decision making.
AB - Differentiating between different types of
neurodegenerative diseases is not only crucial in
clinical practice when treatment decisions have to be
made, but also has a significant potential for the
enrichment of clinical trials. The purpose of this study
is to develop a classification framework for
distinguishing the four most common neurodegenerative
diseases, including Alzheimer's disease, frontotemporal
lobe degeneration, Dementia with Lewy bodies and vascular
dementia, as well as patients with subjective memory
complaints. Different biomarkers including features from
images (volume features, region-wise grading features)
and non-imaging features (CSF measures) were extracted
for each subject. In clinical practice, the prevalence of
different dementia types is imbalanced, posing challenges
for learning an effective classification model.
Therefore, we propose the use of the RUSBoost algorithm
in order to train classifiers and to handle the class
imbalance training problem. Furthermore, a multi-class
feature selection method based on sparsity is integrated
into the proposed framework to improve the classification
performance. It also provides a way for investigating the
importance of different features and regions. Using a
dataset of 500 subjects, the proposed framework achieved
a high accuracy of 75.2% with a balanced accuracy of
69.3% for the five-class classification using ten-fold
cross validation, which is significantly better than the
results using support vector machine or random forest,
demonstrating the feasibility of the proposed framework
to support clinical decision making.
KW - neurodegenerative diseases
KW - differential diagnosis
KW - MRI
KW - dementia
KW - imbalance learning
KW - multi-class feature selection
UR - http://www.scopus.com/inward/record.url?scp=85020929654&partnerID=8YFLogxK
U2 - 10.1016/j.nicl.2017.06.012
DO - 10.1016/j.nicl.2017.06.012
M3 - Article
SN - 2213-1582
VL - 15
SP - 613
EP - 624
JO - NeuroImage: Clinical
JF - NeuroImage: Clinical
ER -